Prospective Evaluation of Disparities in Provision of Allogeneic Transplantation

Overseen By Warren Fingrut, MD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: M.D. Anderson Cancer Center

Disqualifiers: Allogeneic transplant not indicated

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 1

1200 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

To look at the effect of a recipient's ancestry and socio-economic status on their choice of bone marrow transplantation donor cells and their chance of receiving genetically similar (allogeneic) bone marrow cells versus cells that are not genetically similar (allograft).

Who Is on the Research Team?

Warren Fingrut, MD

Principal Investigator

M.D. Anderson Cancer Center

Are You a Good Fit for This Trial?

Inclusion Criteria

I am eligible for a transplant from a donor.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Consent and Questionnaire

Participants sign the consent form and complete a questionnaire about their demographic information and ancestry

1 day

1 visit (in-person)

Data Collection

Information about the participants' medical history, choice of bone marrow donor, and health outcomes is collected from medical records

Up to 2 years

Follow-up

Participants are monitored for safety and effectiveness after transplantation

4 weeks

What Are the Treatments Tested in This Trial?

How Is the Trial Designed?

Group I: Prospective evaluation Experimental Treatment 1 Intervention

Participants are expected to be in this research study for up to 2 years after the participants bone marrow transplantation. However, your active participation will only last 1 day, when you sign the consent form and complete a questionnaire about your demographic information and ancestry (family ethnicity). For the rest of the study, information about the participants medical history, choice of bone marrow donor, and health outcomes will be collected from your medical record.

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials

3,107

Recruited

1,813,000+